×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Session 5 Track 2: How Generative AI is Transforming Medical Writing
Session Chair(s)
Nimita Limaye, PhD
Research Vice President, Life Sciences R&D Strategy and Technology
IDC, United States
This session will discuss how technology players, CROs, and life sciences companies are leveraging AI/GenAI to transform Medical Writing. It will discuss the key use cases that are being implemented, examine the ROI that can be generated, dig into some of the implementation challenges, explore regulatory considerations, change management issues, and how GenAI will completely transform medical writing operations over time.
Learning Objective : - Understand which are the use cases that show promise for the implementation of GenAI in Medical Writing
- Learn how to address some of the implementation challenges related to leveraging GenAI in Medical Writing
- Understand how new business models for medical writing will be structured
- Recognize the key strategies for driving and scaling adoption of GenAI in Medical Writing
Speaker(s)
From Gatherer to Storyteller: How Using an AI Tool is Raising the Value Proposition of Medical Writers in the Writing Process
Julia Forjanic-Klapproth, PhD
Trilogy Writing & Consulting, Germany
Senior Partner
Development of Artificial Intelligence Solutions in Medical Writing: Case Studies, Benefits, and Challenges
James Wolfe, PhD, MS
PAREXEL, France
Vice President, Medical Writing Services
Speaker
Representative Invited
IQVIA, United Kingdom